Professor Yoel Lubell
Contact information
Research groups
Yoel Lubell
Associate Professor
Head of EIRG
I lead the Economics and Implementation Research Group (EIRG) at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, Thailand. EIRG focuses on the evaluation of diagnostics, treatments and vaccines for malaria and other infectious diseases. These evaluations are pursued using a variety of approaches ranging from economic and epidemiological modelling through laboratory investigations to clinical trials and qualitative research. Our ultimate aim is to provide policy makers with pragmatic and context specific assessments of the impact of new interventions if implemented in routine care. Where relevant we strive to take a broader view of the costs and benefits of new interventions accounting for factors such as their indirect impact on disease transmission and antimicrobial resistance, and how the interventions’ cost-effectiveness varies in different epidemiological and socio-economic settings, and in response to contextual factors such as health seeking behaviour and health workers' compliance with diagnostic test results and treatment guidelines.
Key publications
-
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use
Shrestha P. et al, (2018), Antimicrobial Resistance & Infection Control, 7
-
Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial
Do NTT. et al, (2016), The Lancet Global Health, 4, e633 - e641
-
Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review
Drake TL. et al, (2016), Health Economics, 25, 124 - 139
-
Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings
Lubell Y. et al, (2016), PLOS ONE, 11, e0152420 - e0152420
-
Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia
Lubell Y. et al, (2015), BMC Infectious Diseases, 15
Recent publications
-
Point-of-care C-reactive protein testing and antibiotic prescribing.
Althaus T. et al, (2021), The Lancet. Global health, 9
-
Causes of fever in primary care in Southeast Asia and the performance of C-reactive protein in discriminating bacterial from viral pathogens
Althaus T. et al, (2020), International Journal of Infectious Diseases, 96, 334 - 342
-
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance
Turner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
-
Determinants of MDA impact and designing MDAs towards malaria elimination
Gao B. et al, (2020), eLife, 9
-
Sensitivity of C‐reactive protein for the identification of patients with laboratory‐confirmed bacterial infections in northern Tanzania
Althaus T. et al, (2020), Tropical Medicine & International Health, 25, 291 - 300